SEC Form 4 · accession 0001209191-19-013739
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vicente Anido Jr.
Officer — Chief Executive Officer · Director
Period of report
Feb 23, 2019
Accepted (ET)
Feb 26, 2019 · 6:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2019 | F | 1,053 | $40.04 | D | 149,056 | D | |
| Common StockF1 | Feb 24, 2019 | F | 1,527 | $40.04 | D | 147,529 | D | |
| Common StockF1 | Feb 25, 2019 | F | 1,562 | $40.18 | D | 145,967 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.